We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Commentary · November 08, 2020

Eculizumab in Acute Motor Axonal Neuropathy

Journal of Clinical Neuromuscular Disease


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Neuromuscular Disease
Eculizumab in Acute Motor Axonal Neuropathy: An Ethical Application of an Off-Label Indication
J Clin Neuromuscul Dis 2020 Sep 01;22(1)63-64, B Roy, RJ Nowak

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading